VIRTUAL support led by specialists significantly improved quality of life for women with vulvar lichen sclerosus, according to a randomised controlled trial, suggesting structured psychosocial support may be a valuable addition to routine medical management.
Vulvar lichen sclerosus is a chronic inflammatory condition that can substantially affect physical, emotional, and social wellbeing. Although medical treatment addresses disease activity, access to structured psychosocial support remains limited, with many patients relying on unmoderated social media communities for information and advice.
Researchers conducted a randomised controlled trial involving women aged 18 years or older with vulvar lichen sclerosus to evaluate whether expert-led virtual support could improve patient reported quality of life. Participants in the intervention group attended three monthly 60 minute virtual sessions jointly facilitated by a dermatologist and a urogynecologist, while the control group received standard care. The primary outcome was change in Vulvar Quality of Life Index scores between baseline and the final follow up.
The study included 68 participants, with 35 assigned to the intervention group and 33 to the control group.
Women who participated in the virtual support programme experienced significantly greater improvements in overall Vulvar Quality of Life Index scores than those receiving standard care (β=−10.3; 95% CI:−14.9–−5.6; P<0.001). The improvement corresponded to a reduction in disease impact from the Moderate to the Mild severity category.
Significant improvements were also observed across all six domains of the Vulvar Quality of Life Index among participants in the intervention group compared with the control group, demonstrating broad benefits that extended beyond overall quality of life scores.
Qualitative analysis provided further insight into participants’ experiences. Women described expert facilitation as an important source of reassurance and education, while highlighting the value of sharing experiences with others living with vulvar lichen sclerosus.
Participants also reported feeling more empowered to manage their condition and identified structured knowledge sharing as an important benefit of the programme.
The authors concluded that dermatologist and urogynecologist led virtual support groups may represent an accessible, scalable adjunct to medical therapy for vulvar lichen sclerosus. They suggested that integrating structured psychosocial support into routine care could help address an important unmet need for patients living with this chronic condition.
Reference
Kharel A et al. Expert-led virtual support for vulvar lichen sclerosus: a randomized controlled trial. J Cutan Med Surg. 2026. DOI:10.1177/12034754261467041.
Featured: sebra on Adobe Stock
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
